Bearish flow noted in Iovance Biotherapeutics with 1,107 puts trading, or 2x expected. Most active are Jul-24 8 puts and Jan-25 9 calls, with total volume in those strikes near 1,100 contracts. The Put/Call Ratio is 1.81, while ATM IV is up over 14 points on the day. Earnings are expected on August 6th.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IOVA:
- Iovance Biotherapeutics call volume above normal and directionally bullish
- Iovance Biotherapeutics Submits Marketing Authorization Application to European Medicines Agency for Lifileucel in Advanced Melanoma
- Iovance Biotherapeutics submits MAA to EMA for lifileucel
- Jefferies healthcare analyst holds an analyst/industry conference call
- Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)